Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Metz, L."'
Autor:
Comi, G, Cohen, Ja, Arnold, Dl, Wynn, D, Filippi, M, FORTE Study Group, Rocc, Ma, Perego, E, Absinta, M, Mesaros, S, Vuotto, R, Misci, P, Petrolini, M, Coyle, P, Wolinsky, J, Antel, J, Zamvil, S, Feigin, P, Carra, Aj, Bettinelli, Rj, Luetic, Gg, Vrech, Ca, Dubois, Bd, Metz, L, Bar Or, A, Bhan, V, Myles, M, Havrdova, E, Ehler, E, Kanovsky, P, Talab, R, Zapletalova, O, Gross Paju, K, Taba, P, Elovaara, I, Erälinna, Jp, Kinnunen, E, Koivisto, K, Reunanen, M, Brochet, B, Camu, W, Damier, P, Defer, G, Tumani, H, Becker, E, Buettner, T, Diener, Hc, Franz, P, Haas, J, Heesen, C, Heidenreich, F, Koelmel, Hw, Reifschneider, G, Retzlaff, K, Thoemke, F, Ziemssen, T, Rozsa, C, Bartos, L, Csanyi, A, Deme, I, Komoly, S, Panczel, G, Simo, M, Achiron, A, Milo, R, Bergamaschi, R, Bertolotto, A, Capra, R, Caputo, D, Cavalla, P, Centonze, D, Cottone, S, DE STEFANO, Nicola, Gasperini, C, Mancardi, G, Provinciali, L, Ruggieri, S, Scarpini, E, Zaffaroni, M, Metra, M, Kizlaitiene, R, Vaitkus, A, Zwanikken, Cp, Hupperts, Rm, Jongen, Pj, Szczudlik, A, Fryze, W, Kazibutowska, Z, Pierzchaa, K, Pniewski, J, Podemski, R, Stepień, A, Bajenaru, O, Campeanu, A, Marginean, I, Popescu, Cd, Toldisan, I, Boiko, A, Gustov, A, Malkova, N, Perfilyev, S, Poverennova, I, Saykhunov, M, Shutov, A, Skoromets, A, Spirin, N, Stolyarov, I, Volkova, L, Rodriguez Antigüedad, A, Arbizu, T, Arroyo, R, Barcena, J, Casanova, B, Fernández, O, Montalban, X, Ramió, L, Saiz Hinarejos, A, Sharrack, B, Silber, E, Young, C, Agius, M, Birnbaum, G, Campagnolo, D, Chaudhary, K, Cohen, J, Ford, C, Fox, E, Goodman, A, Green, B, Gupta, A, Hughes, B, Javed, A, Jeffery, D, Kasper, L, Kaufman, M, Khan, O, Kresa Reahl, K, Leist, T, Lynch, S, Markowitz, C, Mattson, D, Moses, H, Parks, B, Parry, G, Phillips, T, Picone, M, Rammohan, K, Rizvi, S, Royal, W, Scarberry, S, Sheppard, C, Simnad, V, Thrower, B, Whitham, R, Wynn, D.
Publikováno v:
Annals of Neurology, 69(1), 75-82. Wiley
Objective: To evaluate the safety, tolerability, and efficacy of glatiramer acetate (GA) 40mg compared to a 20mg dose. Methods: Patients with multiple sclerosis (MS) with ≥1 documented relapse in 12 months prior to screening, or ≥2 documented rel
Autor:
Hartung, Hp, Strasser Fuchs, S, Berger, T, Vass, K, Sindic, C, Dubois, B, Dive, D, Debruyne, J, Metz, L, Rice, G, Duquette, P, Lapierre, Y, Freedman, M, Traboulsee, A, O'Connor, P, Stourac, P, Taláb, R, Zapletalová, O, Kováøová, I, Medová, E, Fiedler, J, Frederiksen, J, Brochet, B, Moreau, T, Vermersch, P, Pelletier, J, Edan, G, Clanet, M, Clavelou, P, Lebrun Frenay, C, Gout, O, Kallela, M, Pirttilä, T, Ruutiainen, J, Koivisto, K, Reunanen, M, Elovaara, I, Villringer, A, Altenkirch, H, Wessel, K, Steinke, W, Kölmel, H, Oschmann, P, Diem, R, Dressel, A, Hoffmann, F, Baum, K, Jung, S, Petereit, Hf, Reske, D, Sailer, M, Köhler, J, Sommer, N, Hohlfeld, R, Henn, Kh, Steinbrecher, A, Tumani, H, Gold, R, Rieckmann, P, Komoly, R, Gács, G, Jakab, G, Csiba, L, Vécsei, L, Miller, A, Karussis, D, Chapman, J, Ghezzi, A, Comi, G, Gallo, Paolo, Cosi, V, Durelli, L, Anten, B, Visser, L, Myhr, Km, Szczudlik, A, Selmaj, K, Stelmasiak, Z, Podemski, R, Maciejek, Z, Cunha, L, Sega Jazbec, S, Montalba, X, Arbizu, T, Saiz, A, Bárcena, J, Arroyo, R, Fernández, O, Izquierdo, G, Casanova, B, Lycke, J, Kappos, L, Mattle, H, Beer, K, Coleman, R, Chataway, J, O'Riordan, J, Howell, S. .
Publikováno v:
Neurology, 77(9), 835-843. Lippincott Williams and Wilkins
Hartung, H P, Freedman, M S, Polman, C H, Edan, G, Kappos, L, Miller, D H, Montalban, X, Barkhof, F, Petkau, J, White, R, Sahajpal, V, Knappertz, V, Beckmann, K, Lanius, V, Sandbrink, R & Pohl, C 2011, ' Interferon beta-1b-neutralizing antibodies 5 years after clinically isolated syndrome ', Neurology, vol. 77, no. 9, pp. 835-843 . https://doi.org/10.1212/WNL.0b013e31822c90d7
Neurology, Vol. 77, no.9, p. 835-43 (2011)
Hartung, H P, Freedman, M S, Polman, C H, Edan, G, Kappos, L, Miller, D H, Montalban, X, Barkhof, F, Petkau, J, White, R, Sahajpal, V, Knappertz, V, Beckmann, K, Lanius, V, Sandbrink, R & Pohl, C 2011, ' Interferon beta-1b-neutralizing antibodies 5 years after clinically isolated syndrome ', Neurology, vol. 77, no. 9, pp. 835-843 . https://doi.org/10.1212/WNL.0b013e31822c90d7
Neurology, Vol. 77, no.9, p. 835-43 (2011)
To determine the frequency and consequences of neutralizing antibodies (NAbs) in patients with a first event suggestive of multiple sclerosis (MS) treated with interferon β-1b (IFNβ-1b).In the Betaseron/Betaferon in Newly Emerging MS For Initial Tr
Autor:
Strasser Fuchs, S, Berger, T, Vass, K, Sindic, C, Dubois, B, Dive, D, Debruyne, J, Metz, L, Rice, G, Duquette, P, Lapierre, Y, Freedman, M, Traboulsee, A, O'Connor, P, Stourac, P, Taláb, R, Zapletalová, O, Kovárová, I, Medová, E, Fiedler, J, Frederiksen, J, Brochet, B, Moreau, T, Vermersch, P, Pelletier, J, Edan, G, Clanet, M, Clavelou, P, Lebrun Frenay, C, Gout, O, Kallela, M, Pirttilä, T, Ruutiainen, J, Koivisto, K, Reunanen, M, Elovaara, I, Villringer, A, Altenkirch, H, Wessel, K, Hartung, Hp, Steinke, W, Kölmel, H, Oschmann, P, Diem, R, Dressel, A, Hoff, F, Baum, K, Jung, S, Felicitas Petereit, H, Reske, D, Sailer, M, Köhler, J, Sommer, N, Hohlfeld, R, Henn, Kh, Steinbrecher, A, Tumani, H, Gold, R, Rieckmann, P, Komoly, R, Gács, G, Jakab, G, Csiba, L, Vécsei, L, Miller, A, Karussis, D, Chapman, J, Ghezzi, A, Comi, G, Gallo, Paolo, Cosi, V, Durelli, L, Anten, B, Visser, L, Myhr, Km, Szczudlik, A, Selmaj, K, Stelmasiak, Z, Podemski, R, Maciejek, Z, Cunha, L, Sega Jazbec, S, Montalbán, X, Arbizu, T, Saiz, A, Bárcena, J, Arroyo, R, Fernández, O, Izquierdo, G, Casanova, B, Lycke, J, Kappos, L, Mattle, H, Beer, K, Coleman, R, Chataway, J, O'Riordan, J, Howell, S, Miller, Dh, Polman, Ch, Bauer, L, Ghazi, M, Pohl, C, Sandbrink, R, Barkhof, F, Uitdehaag, B, de Vera, A, Wu, S, Radü, Ew, Mcfarland, Hf, Kesselring, J, Petkau, Aj, Toyka, K. V.
Publikováno v:
Lancet Neurology, 8(11), 987-997. Lancet Publishing Group
Kappos, L, Freedman, M S, Polman, C H, Edan, G, Hartung, H P, Miller, D, Montalban, X, Barkhof, F, Radu, E W, Metzig, C, Bauer, L, Lanius, V, Sandbrink, R & Pohl, C 2009, ' Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial ', Lancet Neurology, vol. 8, no. 11, pp. 987-997 . https://doi.org/10.1016/S1474-4422(09)70237-6
The Lancet Neurology, Vol. 8, no.11, p. 987-97 (2009)
Kappos, L, Freedman, M S, Polman, C H, Edan, G, Hartung, H P, Miller, D, Montalban, X, Barkhof, F, Radu, E W, Metzig, C, Bauer, L, Lanius, V, Sandbrink, R & Pohl, C 2009, ' Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial ', Lancet Neurology, vol. 8, no. 11, pp. 987-997 . https://doi.org/10.1016/S1474-4422(09)70237-6
The Lancet Neurology, Vol. 8, no.11, p. 987-97 (2009)
BACKGROUND: The Betaferon/Betaseron in newly emerging multiple sclerosis for initial treatment (BENEFIT) trial investigated the effect of treatment with interferon beta-1b after a clinically isolated syndrome. The 5-year active treatment extension co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32de5c13d4271bf7c0708befa9bfb69e
https://lirias.kuleuven.be/handle/123456789/257768
https://lirias.kuleuven.be/handle/123456789/257768
Autor:
Sadovnick, AD, Ebers, GC, Dyment, DA, Risch, NJ, Bulman, D, Rice, GPA, Hashimoto, SA, Paty, D, Oger, JJF, Metz, L, Bell, R, Warren, S, Hader, W, Auty, T, Nath, A, Gray, T, OConner, P, Nelson, R, Freedman, M, Brunet, D, Paulseth, R, Francis, G, Duquette, P, Murray, TJ, Bahn, V, PrysePhillips, W
Publikováno v:
The Lancet. 347:1728-1730
BACKGROUND Increased familial risks in multiple sclerosis (MS) range from 300-fold for monozygotic twins to 20-40-fold for biological first-degree relatives, suggesting a genetic influence. Yet if one identical twin has MS the other usually will not.
Autor:
EBERS, G, SADOVNICK, A, RISCH, N, BULMAN, D, RICE, G, HASHIMOTO, S, PATY, D, OGER, J, METZ, L, BELL, R, WARREN, S, HADER, W, AUTY, T, NATH, A, GRAY, T, OCONNOR, P, NELSON, R, FREEDMAN, M, BRUNET, D, PAULSETH, R, FRANCIS, G, DUQUETTE, P, MURRAY, T, BAHN, V, PRYSEPHILLIPS, W
Publikováno v:
Nature. 377:150-151
GENETIC-environmental interactions probably underlie spontaneous human autoimmune disorders, a category of complex traits thought to include multiple sclerosis (MS)1. The geographical distribution and familial aggregation of this disease have often b
Publikováno v:
European Urology. 14:251-252
The application of microsurgery to repair the injured ureter using a double-layer end-to-end anastomosis is described and 2 cases are reported. The results in both cases are excellent.
Autor:
Luanne M. Metz, Jai Perumal, Corey C. Ford, Kenneth P. Johnson, Mark Tullman, R. P. Lisak, Alexandros Tselis, Omar Khan, Massimo Filippi
The past decade has witnessed a revolution in the treatment of multiple sclerosis (MS), the most common demyelinating disorder of the human CNS. After being considered as an untreatable disease for more than a century, six disease-modifying treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bba2e7a239aa7046a37a7ce274e2967